exp7711 has been researched along with saralasin in 1 studies
| Studies (exp7711) | Trials (exp7711) | Recent Studies (post-2010) (exp7711) | Studies (saralasin) | Trials (saralasin) | Recent Studies (post-2010) (saralasin) |
|---|---|---|---|---|---|
| 18 | 0 | 1 | 1,497 | 13 | 16 |
| Protein | Taxonomy | exp7711 (IC50) | saralasin (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0006 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaine, EH; Koepke, JP; Smits, GJ | 1 |
1 other study(ies) available for exp7711 and saralasin
| Article | Year |
|---|---|
Reversal of low dose angiotension hypertension by angiotensin receptor antagonists.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Infusions, Intravenous; Male; Rats; Rats, Inbred Strains; Saralasin | 1991 |